Position statement: Ipecac syrup

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 7, 1997, Pages 699-709

  Krenzelok, E P ^a   McGuigan, M ^a   Lheur, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CARBON; AMINOPHYLLINE; AMPICILLIN; ANTIDOTE; BARIUM; CEPHAELINE; CIMETIDINE; CYANOCOBALAMIN; EMETINE; FERROUS SULFATE; HYDROCARBON; IPECAC; MAGNESIUM HYDROXIDE; MARKER; PARACETAMOL; PINDOLOL; SALICYLATE SODIUM; SUCRALFATE; TETRACYCLINE; THIAMINE;

CLINICAL TRIAL; CONSCIOUSNESS DISORDER; DIARRHEA; DROWSINESS; DRUG CONTRAINDICATION; DRUG INDICATION; EMERGENCY WARD; HUMAN; INTESTINE LAVAGE; INTOXICATION; LETHARGY; NONHUMAN; REVIEW; SCIENTIFIC LITERATURE; SYRUP; TREATMENT OUTCOME; VOMITING;

CEPHAELIS IPECACUANHA;

EID: 0031415531     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709162567     Document Type: Review

References (41)

1. Arnold FJ, Hodges Jr JB, Barta Jr RA. Evaluation of the efficacy of lavage and induced emesis in treatment of salicylate poisoning. Pediatrics 1959;23:286-301.
2. Abdallah AH, Tye A. A comparison of the efficacy of emetic drugs and stomach lavage. Am J Dis Child 1967;113:571-575.
3. Corby DG, Lisciandro RC, Lehman RH, Decker WJ. The efficiency of methods used to evacuate the stomach after acute ingestions. Pediatrics 1967;40: 871-874.
4. Teshima D, Suzuki A, Otsubo K, et al. Efficacy of emetic and United States Pharmacopoeia ipecac syrup in prevention of drug absorption. Chem Pharm Bull 1990;38:2242-2245.
5. Neuvonen PJ, Vartiainen M, Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol 1983;24: 557-562.
6. Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Arch Intern Med 1984;144:48-52.
7. Neuvonen PJ, Olkkola KT. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent. J Toxicol Clin Toxicol 1984;22:103-114.
8. Tandberg D, Diven BG, McLeod JW. Ipecac-induced emesis versus gastric lavage. Am J Emerg Med 1986;4:205-209.
9. Tenenbein M, Cohen S, Sitar DS. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med 1987;16:838-841.
10. Danel V, Henry JA, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. BMJ 1988;296:1507.
11. Vasquez TE, Evans DG, Ashburn WL. Efficacy of syrup of ipecac-induced emesis for emptying gastric contents. Clin Nucl Med 1988;13:638-639.
12. McNamara RM, Aaron CK, Gemborys M, Davidheiser S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med 1989;18: 934-938.
13. Tandberg D, Murphy LC. The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am J Emerg Med 1989;7:267-270.
14. Young WF, Bivins HG. Evaluation of gastric emptying using radionuclides: Gastric lavage versus ipecac-induced emesis. Ann Emerg Med 1993;22: 1423-1427.
15. Bond GR, Requa RK, Krenzelok EP, et al. Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population. Ann Emerg Med 1993;22:1403-1407.
16. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985;14:562-567.
17. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 1995;163:345-349.
18. Chafee-Bahamon C, Lacouture PG, Lovejoy FH Jr. Risk assessment of ipecac in the home. Pediatrics 1985;75:1105-1109.
19. Czajka PA, Russell SL. Nonemetic effects of ipecac syrup. Pediatrics 1985;75:1101-1104.
20. Litovitz TL, Klein-Schwartz W, Oderda GM, et al. Ipecac administration in children younger than 1 year of age. Pediatrics 1985;76:761-764.
21. Litovitz TL, Smilkstein M, Felberg L, et al. 1996 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1997;15:447-500.
22. Corby DG, Decker WJ, Moran MJ, Payne CE. Clinical comparison of pharmacologic emetics in children. Pediatrics 1968;42:361-364.
23. Auerbach PS, Osterloh J, Braun O, et al. Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac. Ann Emerg Med 1986;15:692-698.
24. Saetta JP, March S, Gaunt ME, Quinton DN. Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus? J R Soc Med 1991;84:274-276.
25. Merigian KS, Woodard M, Hedges JR, Roberts JR, Stuebling R, Rashkin MC. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990;8:479-483.
26. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med 1991;20:648-651.
27. Bond GR. Home use of syrup of ipecac is associated with a reduction in pediatric emergency department visits. Ann Emerg Med 1995;25:338-343.
28. Amitai Y, Mitchell AA, McGuigan MA, Lovejoy Jr FH. Ipecac-induced emesis and reduction of plasma concentrations of drugs following accidental overdose in children. Pediatrics 1987;80:364-367.
29. Underhill TJ, Greene MK, Dove AF. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med 1990;7: 148-154.
30. Saetta JP, Quinton DN. Residual gastric content after gastric lavage and ipecacuanha-inducedemesis in self-poisoned patients: an endoscopic study. J R Soc Med 1991;84:35-38.
31. Tenenbein M. Inefficacy of gastric emptying procedures. J Emerg Med 1985;3:133-136.
32. Peterson CD, Fifield GC. Emergency gastrotomy for acute iron poisoning. Ann Emerg Med 1980;9: 262-264.
33. Landsman I, Bricker JT, Reid BS, Bloss RS. Emergency gastrotomy: Treatment of choice of iron bezoar. J Pediatr Surg 1987;22:184-185.
34. Albertson TE, Derlet RW, Foulke GE, Minguillon MC, Tharratt SR. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann Emerg Med 1989;18:56-59.
35. Tanberg D, Liechty EJ, Fishbein D. Mallory-Weiss Syndrome: An unusual complication of ipecac-induced emesis. Ann Emerg Med 1981;10:521-523.
36. Timberlake GA. Ipecac as a cause of the Mallory-Weiss Syndrome. South Med J 1984;77:804-805.
37. Wolowodiuk OK, McMicken DB, O'Brein P. Pneumomediastinum and retropneumo-peritoneum: an unusual complication of syrup-of-ipecac-induced emesis. Ann Emerg Med 1984;13:1148-1151.
38. Wrenn K, Rodenwald L, Docstader L. Potential misuse of ipecac. Ann Emerg Med 1993;22: 1408-1422.
39. Robertson WO. Syrup of ipecac associated fatality: A case report. Vet Hum Toxicol 1979;21:87-89.
40. Klein-Schwartz W, German RL, Oderda GM, Wedin GP, Saggar D. Ipecac use in the elderly: the unanswered question. Ann Emerg Med 1984;13: 1152-1154.
41. Knight KM, Doucet HJ. Gastric rupture and death caused by ipecac syrup. South Med J 1987;80: 786-787.